185 related articles for article (PubMed ID: 29277062)
1. The yeast stands alone: the future of protein biologic production.
Love KR; Dalvie NC; Love JC
Curr Opin Biotechnol; 2018 Oct; 53():50-58. PubMed ID: 29277062
[TBL] [Abstract][Full Text] [Related]
2. Production of Protein Complexes in Non-methylotrophic and Methylotrophic Yeasts : Nonmethylotrophic and Methylotrophic Yeasts.
Fernández FJ; López-Estepa M; Querol-García J; Vega MC
Adv Exp Med Biol; 2016; 896():137-53. PubMed ID: 27165323
[TBL] [Abstract][Full Text] [Related]
3. Recombinant protein production in yeasts.
Mattanovich D; Branduardi P; Dato L; Gasser B; Sauer M; Porro D
Methods Mol Biol; 2012; 824():329-58. PubMed ID: 22160907
[TBL] [Abstract][Full Text] [Related]
4. Yeast synthetic biology for the production of recombinant therapeutic proteins.
Kim H; Yoo SJ; Kang HA
FEMS Yeast Res; 2015 Feb; 15(1):1-16. PubMed ID: 25130199
[TBL] [Abstract][Full Text] [Related]
5. Biopharmaceutical discovery and production in yeast.
Meehl MA; Stadheim TA
Curr Opin Biotechnol; 2014 Dec; 30():120-7. PubMed ID: 25014890
[TBL] [Abstract][Full Text] [Related]
6. Biomedical applications of yeast- a patent view, part one: yeasts as workhorses for the production of therapeutics and vaccines.
Roohvand F; Shokri M; Abdollahpour-Alitappeh M; Ehsani P
Expert Opin Ther Pat; 2017 Aug; 27(8):929-951. PubMed ID: 28608761
[TBL] [Abstract][Full Text] [Related]
7. Current achievements, strategies, obstacles, and overcoming the challenges of the protein engineering in Pichia pastoris expression system.
Eskandari A; Nezhad NG; Leow TC; Rahman MBA; Oslan SN
World J Microbiol Biotechnol; 2023 Dec; 40(1):39. PubMed ID: 38062216
[TBL] [Abstract][Full Text] [Related]
8. Which yeast species shall I choose? Saccharomyces cerevisiae versus Pichia pastoris (review).
Darby RA; Cartwright SP; Dilworth MV; Bill RM
Methods Mol Biol; 2012; 866():11-23. PubMed ID: 22454110
[TBL] [Abstract][Full Text] [Related]
9. Towards systems metabolic engineering in Pichia pastoris.
Schwarzhans JP; Luttermann T; Geier M; Kalinowski J; Friehs K
Biotechnol Adv; 2017 Nov; 35(6):681-710. PubMed ID: 28760369
[TBL] [Abstract][Full Text] [Related]
10. Advances in engineered microorganisms for improving metabolic conversion via microgravity effects.
Huangfu J; Zhang G; Li J; Li C
Bioengineered; 2015; 6(4):251-5. PubMed ID: 26038088
[TBL] [Abstract][Full Text] [Related]
11. Non-conventional yeast cell factories for sustainable bioprocesses.
Rebello S; Abraham A; Madhavan A; Sindhu R; Binod P; Karthika Bahuleyan A; Aneesh EM; Pandey A
FEMS Microbiol Lett; 2018 Nov; 365(21):. PubMed ID: 30212856
[TBL] [Abstract][Full Text] [Related]
12. Customized yeast cell factories for biopharmaceuticals: from cell engineering to process scale up.
Madhavan A; Arun KB; Sindhu R; Krishnamoorthy J; Reshmy R; Sirohi R; Pugazhendi A; Awasthi MK; Szakacs G; Binod P
Microb Cell Fact; 2021 Jun; 20(1):124. PubMed ID: 34193127
[TBL] [Abstract][Full Text] [Related]
13. Synthetic biology and microbioreactor platforms for programmable production of biologics at the point-of-care.
Perez-Pinera P; Han N; Cleto S; Cao J; Purcell O; Shah KA; Lee K; Ram R; Lu TK
Nat Commun; 2016 Jul; 7():12211. PubMed ID: 27470089
[TBL] [Abstract][Full Text] [Related]
14. Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.
Berlec A; Strukelj B
J Ind Microbiol Biotechnol; 2013 Apr; 40(3-4):257-74. PubMed ID: 23385853
[TBL] [Abstract][Full Text] [Related]
15. A yeast for all seasons - Is Pichia pastoris a suitable chassis organism for future bioproduction?
Gasser B; Mattanovich D
FEMS Microbiol Lett; 2018 Sep; 365(17):. PubMed ID: 30052876
[TBL] [Abstract][Full Text] [Related]
16. Heterologous expression of a fungal sterol esterase/lipase in different hosts: Effect on solubility, glycosylation and production.
Vaquero ME; Barriuso J; Medrano FJ; Prieto A; Martínez MJ
J Biosci Bioeng; 2015 Dec; 120(6):637-43. PubMed ID: 25939548
[TBL] [Abstract][Full Text] [Related]
17. Genome-scale metabolic model of methylotrophic yeast Pichia pastoris and its use for in silico analysis of heterologous protein production.
Sohn SB; Graf AB; Kim TY; Gasser B; Maurer M; Ferrer P; Mattanovich D; Lee SY
Biotechnol J; 2010 Jul; 5(7):705-15. PubMed ID: 20503221
[TBL] [Abstract][Full Text] [Related]
18. Recombinant protein subunit vaccine synthesis in microbes: a role for yeast?
Bill RM
J Pharm Pharmacol; 2015 Mar; 67(3):319-28. PubMed ID: 25556638
[TBL] [Abstract][Full Text] [Related]
19. Yeast metabolic engineering for the production of pharmaceutically important secondary metabolites.
Rahmat E; Kang Y
Appl Microbiol Biotechnol; 2020 Jun; 104(11):4659-4674. PubMed ID: 32270249
[TBL] [Abstract][Full Text] [Related]
20. Rapid screening of cellular stress responses in recombinant Pichia pastoris strains using metabolite profiling.
Tredwell GD; Aw R; Edwards-Jones B; Leak DJ; Bundy JG
J Ind Microbiol Biotechnol; 2017 Mar; 44(3):413-417. PubMed ID: 28160205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
